LSD
Articles
APPROVAL OF LSD AS A SINGLE-DOSE MEDICATION IS MOVING FORWARD...
On Monday, June 22, 2026, Definium Therapeutics announced positive preliminary results from its Phase 3 study of LSD (DT120) for major depressive disorder (MDD). These are the first Phase 3 results for both the company and LSD.The data showed a...
0
min.

